CBS 2019
CBSMD教育中心
English

急性冠脉综合征

科研文章

荐读文献

High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial Changes in One-Year Mortality in Elderly Patients Admitted with Acute Myocardial Infarction in Relation with Early Management Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI Incidence and Outcomes of Acute Coronary Syndrome After Transcatheter Aortic Valve Replacement Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Ca Optimum Blood Pressure in Patients With Shock After Acute Myocardial Infarction and Cardiac Arrest Association of Parenteral Anticoagulation Therapy With Outcomes in Chinese Patients Undergoing Percutaneous Coronary Intervention for Non-ST-Segment Elevation Acute Coronary Syndrome Early versus delayed invasive intervention in acute coronary syndromes
|<<... 13 14 15 16 17 18 19 ...>>|

Original Research1 Sep 2019

JOURNAL：Circulation. Article Link

High-Sensitivity Troponin and The Application of Risk Stratification Thresholds in Patients with Suspected Acute Coronary Syndrome

A Bularga, KK Lee, the High-STEACS Investigators et al. Keywords: high-sensitivity cardiac troponin; suspected ACS; risk stratification threshold

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top